PAINREFORM LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8455 USD | +5.67% |
|
+8.40% | -69.25% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 39.83 | 13.94 | 4.389 | 4.285 | 2.092 | - | - |
| Enterprise Value (EV) 1 | 39.83 | 13.94 | 4.389 | 4.285 | 2.092 | 2.092 | 2.092 |
| P/E ratio | -3.58 x | -1.8 x | -0.5 x | -0.39 x | -0.24 x | -0.42 x | -0.57 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / FCF | -1,55,15,480 x | - | - | - | - | - | - |
| FCF Yield | -0% | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 891 | 1,048 | 1,063 | 1,558 | 2,474 | - | - |
| Reference price 2 | 44.70 | 13.30 | 4.127 | 2.750 | 0.8455 | 0.8455 | 0.8455 |
| Announcement Date | 18/03/21 | 16/03/22 | 15/03/23 | 29/02/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | - | -1.671 | -7.208 | -8.869 | -9.584 | -22.1 | -26.01 | -26.49 |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | -3.833 | -7.24 | -8.783 | -9.336 | -22.04 | -26.01 | -26.49 |
| Net income 1 | -1.279 | -4.053 | -7.246 | -8.792 | -9.344 | -22.04 | -26.01 | -26.49 |
| Net margin | - | - | - | - | - | - | - | - |
| EPS 2 | -13.90 | -12.50 | -7.400 | -8.200 | -7.140 | -3.500 | -2.020 | -1.480 |
| Free Cash Flow | - | -2.567 | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 30/06/20 | 18/03/21 | 16/03/22 | 15/03/23 | 29/02/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -1.741 | -1.672 | -1.845 | -2.096 | -3.256 | -2.416 | -2.252 | -1.352 | -3.564 | -5.565 | -5.676 | -5.79 | -5.067 |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -1.727 | -1.694 | -1.823 | -2.109 | -3.157 | -2.308 | -2.181 | 0.036 | -4.883 | -5.506 | -5.676 | -5.79 | -5.067 |
| Net income 1 | -1.733 | -1.694 | -1.823 | -2.109 | -3.166 | -2.308 | -2.181 | 0.036 | -4.891 | -5.506 | -5.676 | -5.79 | -5.067 |
| Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | -1.700 | -1.600 | -1.700 | -2.000 | -2.900 | -2.200 | -1.920 | 0.4800 | -3.500 | -2.720 | -1.040 | -0.8800 | -0.4400 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 16/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 15/03/23 | 15/05/23 | 10/08/23 | 15/11/23 | 29/02/24 | 15/05/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | -2.57 | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - | - |
| Announcement Date | 30/06/20 | 18/03/21 | 16/03/22 | 15/03/23 | 29/02/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.8455
USD
Average target price
2
USD
Spread / Average Target
+136.55%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -69.25% | 2.09M | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- PRFX Stock
- Financials PainReform Ltd.
